Form 8-K - Current report:
SEC Accession No. 0001641172-25-011873
Filing Date
2025-05-21
Accepted
2025-05-21 09:00:09
Documents
13
Period of Report
2025-05-20
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42715
  Complete submission text file 0001641172-25-011873.txt   260745

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE drma-20250520.xsd EX-101.SCH 3781
3 XBRL DEFINITION FILE drma-20250520_def.xml EX-101.DEF 30042
4 XBRL LABEL FILE drma-20250520_lab.xml EX-101.LAB 36718
5 XBRL PRESENTATION FILE drma-20250520_pre.xml EX-101.PRE 27065
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5841
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 25971019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)